Jobs / United States / Gilead Sciences INC

Senior Director, Clinical Development (MD)

Gilead Sciences INC · 🇺🇸 4 Locations

Sponsorship verdict

Sponsorship possible

One solid signal, not two — worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
  • What Gilead Sciences INC paid sponsored hires in similar roles1 certified filing for “Associate Clinical Pharmacology Director” (Natural Sciences Managers) in NJ: $184k–$184k, median $184k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
  • Confirmed live todayWhen a source last listed this job as open.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.

Start free →

Or apply yourself on the official page →

Sponsor Radar — Gilead Sciences INC

159 H-1B filings certified since Oct 2025

The US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).

Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Gilead Sciences INC →

About the role

We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet. Join Kite, as we make even bigger advances in cancer therapies, and help shape where our business and medical science goes next. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Kite and help create more tomorrows. Job Description The Senior Medical Director provides strategic and scientific leadership for one or more development programs and serves as the clinical development lead from early development through registration planning, as applicable. The role is responsible for shaping clinical development strategy, overseeing execution across multiple studies, and partnering with cross-functional teams to advance programs in alignment with corporate objectives. The Senior Medical Director is expected to influence development decisions, represent clinical development to senior leadership and external stakeholders, and contribute to portfolio and lifecycle planning. Job Responsibilities • Lead the clinical development strategy for one or more oncology programs, providing scientific and medical leadership from IND-enabling activities through proof-of-concept and early development milestones. • Provide clinical oversight and medical monitoring across one or more clinical studies, ensuring participant safety, data integrity, and high-quality execution. • Lead cross-functional teams in the design, implementation, and execution of clinical development plans and clinical studies. • Author and review protocols, investigator brochures, clinical study reports, regulatory documents, and other key clinical development deliverables. • Provide strategic leadership for regulatory interactions and submissions, including INDs, health authority meetings, regulatory responses, as applicable. • Collaborate with Research, Translational Sciences, Clinical Operations, Safety, Regulatory Affairs, and CMC teams to advance development programs and achieve key milestones. • Build and maintain relationships with investigators, key opinion leaders, scientific advisors, and other external stakeholders. • Present clinical data and development strategies to governance committees, health authorities, scientific conferences, and investigator meetings; lead or contribute to scientific publications and presentations. • Mentor junior physicians and contribute to portfolio strategy, business development evaluations, and external innovation assessments, as applicable.   Basic Qualifications MD/DO with 6+ years of clinical, scientific and/or drug development experience, including substantial experience in biopharmaceutical clinical development Preferred Qualifications • Board certification in Hematology/Oncology or a related specialty. • Significant experience leading oncology drug development programs with responsibility for clinical strategy and execution. • Demonstrated experience leading first-in-human, proof-of-concept, and registrational development programs. • Cell therapy experience preferred, including autologous, allogeneic, and/or in vivo cellular therapy platforms. • Experience leading interactions with global health authorities and supporting major regulatory submissions. • Demonstrated ability to influence cross-functional tea

View the official posting →

Source: Employer career site (Workday) First seen: 2026-10-01 Last confirmed: 2026-10-03 How our data works → Report this job

Similar opportunities